People 65 years and older and those who are moderately or severely immunocompromised should receive a second dose of 2024-2025 COVID-19 vaccine six months after their first dose. See the CDC's updated guidance. More Info
Online training is available and recommended for anyone supporting testing efforts.
For the Abbott BinaxNow test, training and information is available at: https://www.globalpointofcare.abbott/en/support/product-installation-training/navica-brand/navica-binaxnow-ag-training.html
For BD Veritor test, training and information is available at: https://www.bdveritor.com/training/